GRMN
52
-3
FRT
53
3
AMG
47
-5
ACN
54
2
MO
54
-2
SRE
63
-3
BWA
52
-3
PRU
44
-7
ZION
61
-3
VTR
44
-3
PVH
54
-4
ALL
58
2
EXPE
67
3
NI
73
-5
PM
79
-2
AVB
54
2
WYNN
34
-3
MNST
63
-2
BBY
50
-5
CSCO
67
-3
GRMN
52
-3
FRT
53
3
AMG
47
-5
ACN
54
2
MO
54
-2
SRE
63
-3
BWA
52
-3
PRU
44
-7
ZION
61
-3
VTR
44
-3
PVH
54
-4
ALL
58
2
EXPE
67
3
NI
73
-5
PM
79
-2
AVB
54
2
WYNN
34
-3
MNST
63
-2
BBY
50
-5
CSCO
67
-3
Financhill
Back

Vaxcyte Stock Predictions

Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
27

PCVX
Vaxcyte

Last Price:
$32.78
Seasonality Move:
12.84%

7 Day Trial

ALL ACCESS PASS

$ 7

10 Best Stocks to Own in 2025

Get your copy now FREE!

Vaxcyte Stock Forecast

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 24.4% based on the past 4 years of stock performance.
  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Vaxcyte Stock Undervalued?
    The current Vaxcyte [PCVX] share price is $31.38. The Score for PCVX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • PCVX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Vaxcyte Stock Go Up Next Year?

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 24.4% based on the past 4 years of stock performance.

Vaxcyte Stock Rating

Sell
27
Vaxcyte (PCVX) is a Sell

Is Vaxcyte overpriced?

  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Vaxcyte Stock Price History

Is PCVX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCVX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vaxcyte.com

52-Week Data

52-Week High:
121.06
52-Week Low:
27.66

Prediction Charts

Market Cap:
4B
Price in USD:
31.38
Volume:
2.4M
Beta:
1.29

Technical Analysis

SMA50:
39.45
SMA100:
60.91
SMA200:
79.61
52-Wk Change:
-54.32%

Stock Predictions

  • Is Vaxcyte stock public?
    Yes, Vaxcyte is a publicly traded company.
  • What is the Vaxcyte stock quote today?
    The Vaxcyte stock price is 31.38 USD today.
  • How to buy Vaxcyte stock online?
    You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-9 31.29 31.16 33.47 31.07
May-12 32.49 31.59 32.99 31.42
May-13 31.69 30.05 32.02 29.99
May-14 30.07 29.42 30.38 28.64
May-15 29.56 30.90 31.15 29.00
May-16 30.97 31.85 32.53 30.65
May-19 31.23 32.03 32.81 31.23
May-20 32.08 36.57 36.63 31.58
May-21 36.00 33.97 36.84 33.74
May-22 33.68 33.95 34.18 32.98
May-23 33.26 32.54 33.80 32.36
May-27 33.24 31.73 33.28 31.07
May-28 31.64 31.38 32.60 31.20
May-29 31.77 32.80 33.31 31.57

Vaxcyte Earnings

Vaxcyte Earnings Report: Per Share Vaxcyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vaxcyte Forecast Revenue Growth

Vaxcyte Stock Analysis: Historical quarterly revenues per share for Vaxcyte and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.52 per share.

* Vaxcyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.